| Valuation method | Value, ¥ | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 1263.88 | 145 |
| Intrinsic value (DCF) | 195.60 | -62 |
| Graham-Dodd Method | n/a | |
| Graham Formula | n/a |
Data Horizon Corporation (3628.T) is a Japan-based healthcare information services provider specializing in data health support for insurers. Founded in 1981 and headquartered in Hiroshima, the company offers medical information services, including health-related data analytics and generic drug notification services, as well as a health business support system. Operating as a subsidiary of DeNA Co., Ltd., Data Horizon serves the Japanese healthcare sector by leveraging data-driven insights to improve insurer operations and patient outcomes. The company operates in the rapidly growing healthcare IT sector, where digital transformation and data utilization are becoming critical for insurers and medical providers. With Japan's aging population and increasing healthcare costs, Data Horizon's services are positioned to address key industry challenges, though competition remains intense in this niche market.
Data Horizon Corporation presents a mixed investment profile. While the company operates in a high-growth segment (healthcare IT) with strong sector tailwinds, its financial performance has been weak, reporting a net loss of ¥807 million and negative EPS (-¥63.7) in the latest fiscal year. The company's modest market cap (¥5.72 billion) and low beta (0.769) suggest limited volatility but also constrained growth prospects. Positive operating cash flow (¥120 million) is overshadowed by significant capital expenditures (¥799 million), indicating heavy reinvestment needs. With no dividend payout and a leveraged balance sheet (¥2.46 billion debt vs. ¥1.42 billion cash), the stock may appeal only to speculative investors betting on a turnaround or acquisition by parent company DeNA.
Data Horizon Corporation competes in Japan's specialized healthcare IT market, where its key advantage lies in its long-standing insurer relationships and niche focus on data health support services. As a subsidiary of DeNA, it may have access to broader tech resources, but its small scale limits R&D capabilities compared to larger players. The company's services are tailored to Japan's unique healthcare system, providing some insulation from global competitors, but it faces intense domestic competition from firms with deeper healthcare IT expertise. Its financial struggles (consistent losses) suggest weaker competitive positioning versus profitable peers. The lack of international presence further restricts growth potential. Data Horizon's value proposition hinges on its insurer-specific data solutions, but it must improve profitability to sustain its market position against well-funded rivals expanding into AI and big data analytics for healthcare.